|
What
to Expect During Treatment with INTRON® A
Chronic
Hepatitis B:
The
treatment for chronic hepatitis B usually involves taking injections
of INTRON A for Injection for 4 months. About half of all patients
with chronic hepatitis B who are treated with interferon will have
some benefit from the treatment - there will be less virus in their
blood, their liver damage may slow down, and their symptoms will
improve. In clinical studies, 45% of patients who are treated for
chronic hepatitis B with INTRON® A have no evidence of the hepatitis
virus in their blood over time.
While
you are being treated, your doctor may regularly check your alanine
aminotransferase (ALT) levels to see if your liver is still inflamed.
He or she may also use the anti-HBeAg or the HBV-DNA test to see
if there is still virus in your blood, and how much there is. It
can take a while for all evidence of the virus to clear from your
blood. As a result, your HBsAg test may still be positive for weeks
to years after you have been treated. Many patients get rid of the
virus for good, but on rare occasions patients may have a relapsea
return of the infectionbecause the drug will not have completely
cleared the virus from the body.
Even
if the virus is controlled, it can take time for your liver to recover
from the infection. Despite the absence of virus, the liver needs
time to grow healthy new cells to replace those that were damaged
or destroyed by the infection.
Chronic
Hepatitis C:
The
antibodies your body produces to defend against hepatitis B work
much better than those directed at hepatitis C.
(An antibody is a type of immune protein molecule that is produced
when a virus enters the body.)
As
a result, your body more often needs help beating chronic hepatitis
C. INTRON® A (Interferon alfa-2b, recombinant) for Injection is
usually given 3 times a week, and treatment often lasts much longer
for hepatitis C than for chronic hepatitis B. If taken alone and
not as part of REBETRON Combination Therapy containing REBETOL®
(Ribavirin, USP) Capsules and INTRON® A (Interferon alfa-2b, recombinant)
Injection, INTRON® A may take anywhere from 18 to 24 months for
your treatment to be completed.
During
treatment, your doctor will carefully follow your alanine aminotransferase
(ALT) levels and HCV-RNA levels and do other tests to see if your
liver is getting better with treatment.
Studies
have suggested that longer treatment with INTRON® A
leads to better results. These benefits may include periods of remission
and a lower risk of developing cirrhosis and/or liver cancer. Therefore,
it is very important that you follow your treatment plan through completion
as the doctor recommended. Follow-up with your doctor is very important.
Even if you have no sign of the virus in your body at the end of treatment,
the chances are greater than 70% that you may suffer a relapse. If this happens,
your doctor may consider REBETRON Combination Therapy.
Choose
a topic below:
|